The majority of tumours were IDH wild type (74.7%) and MGMT promoter unmethylated (43.7%), whereas 17.3% had unknown IDH status and 17.1% had unknown MGMT promoter methylation status. The gene discussed is IDH2; the disease is neoplasm.